General
Preferred name
HALOPROGIN
Synonyms
Benzene, 1,2,4-trichloro-5-((3-iodo-2-propynyl)oxy)- ()
Haloprogina ()
Mycanden ()
M-1028 ()
Halotex ()
NSC-100071 ()
Haloprogine ()
P&D ID
PD009717
CAS
777-11-7
Tags
available
drug
Approved by
FDA
Drug indication
Candidiasis
Antibacterial
Dermatophytosis
Drug Status
approved
withdrawn
Max Phase
4.0
First approval
1982
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
1
Compound Sets
17
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
32
Properties
(calculated by RDKit )
Molecular Weight
359.84
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
0
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
4.42
TPSA
9.23
Fraction CSP3
0.11
Chiral centers
0.0
Largest ring
6.0
QED
0.43
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
tinea pedis
MOA
other antifungal
ATC
D01AE11
Therapeutic Class
Antifungal Agents
Pathway
Anti-infection
Target
Fungal
Source data
